Global Specialty Focus Ever Pharma operates in neurology and specialty injectables with EU GMP manufacturing and distribution to over 70 countries, presenting opportunities to expand neurodegenerative therapies, high-potency injectables, and controlled substances across international markets through current affiliates and partners.

Parkinsons Tailored Offerings Recent and historic launches around D-mine Pump, D-mine Pen, and Dacepton position Ever Pharma as a partner for advanced microinfusion therapies in Parkinson’s disease, suggesting upsell opportunities in device-enabled delivery, patient support programs, and combination regimens with existing dopaminergic therapies.

Therapeutic Portfolio Expansion Strong emphasis on neurology, oncology, intensive care, and hormone therapeutics implies cross-sell potential into adjacent specialty injectables, injectable platforms, and high-potency formulation services for partners seeking EU GMP manufacturing, finished dosage forms, and complex packaging.

Strategic Partnerships Distribution deal with Kalceks and multi-country marketing footprint indicate readiness to scale through regional partnerships, enabling co-development, import/export collaborations, and channel optimization in high-growth European markets and beyond.

Operational Capability EU GMP certified facilities in Austria and Germany with expertise in complex injectables, high potency products, and crystal suspensions provide a compelling value proposition for contract development and manufacturing, enabling prospective clients to outsource manufacturing with regulatory confidence.